🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objective of the study is to evaluate the change in liver copper (...
Status
Completed
Location
Research Site
Start Date
2020-12-02
Trial ID
NCT04422431
Treatments Being Tested
The study will assess the change from baseline in mean daily copper balance...
Status
Completed
Location
Clinical Study Site
Start Date
2020-07-01
Trial ID
NCT04594252
Treatments Being Tested
This is a Phase 1, randomized, 2-period, 2-sequence, cross-over study desig...
Status
Completed
Location
Clinical Trial Site
Start Date
2020-10-21
Trial ID
NCT04526210
Treatments Being Tested
This is an open-label, single-arm, multi-center EAP, designed to provide ea...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05686564
Treatments Being Tested
This exploratory study will investigate the effects of ALXN1840 on copper b...
Status
Completed
Location
Research Site
Start Date
2020-09-07
Trial ID
NCT04573309
Treatments Being Tested
The main purpose of the study was to evaluate the efficacy of ALXN1840 (for...
Status
Completed
Location
Clinical Trial Site
Start Date
2014-11-24
Trial ID
NCT02273596
Treatments Being Tested
The study will assess the relative bioavailability of 2 different formulati...
Status
Completed
Location
Nucleus Network Pty Ltd.
Start Date
2021-01-31
Trial ID
NCT04610580
Treatments Being Tested
This study will evaluate the effect of a supratherapeutic dose of ALXN1840 ...
Status
Completed
Location
PPD Development, LP
Start Date
2020-07-24
Trial ID
NCT04560816
Treatments Being Tested
This was single-center, open-label, randomized, 3-period, 3-treatment, 6-se...
Status
Completed
Location
Clinical Trial Site
Start Date
2014-04-07
Trial ID
NCT05319912
Treatments Being Tested
This was single-center, open-label, randomized, 3-period, 3-treatment, 6-se...
Status
Completed
Location
Clinical Trial Site
Start Date
2014-01-20
Trial ID
NCT05319899
Treatments Being Tested